Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Simplified Phenotypic Scheme Evaluated by 16S rRNA Sequencing for Differentiation between Yersinia enterocolitica and Y. enterocolitica-Like species

Saija Hallanvuo, Joanna Peltola, Tarja Heiskanen, Anja Siitonen
Saija Hallanvuo
1Enteric Bacteria Laboratory (EBL), National Public Health Institute (KTL), FIN-00300 Helsinki
2Environmental and Food Research Laboratory, Municipal Joint Union for Public Health in the Hämeenlinna Region, FIN-13111 Hämeenlinna, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Peltola
1Enteric Bacteria Laboratory (EBL), National Public Health Institute (KTL), FIN-00300 Helsinki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarja Heiskanen
1Enteric Bacteria Laboratory (EBL), National Public Health Institute (KTL), FIN-00300 Helsinki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anja Siitonen
1Enteric Bacteria Laboratory (EBL), National Public Health Institute (KTL), FIN-00300 Helsinki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anja.siitonen@ktl.fi
DOI: 10.1128/JCM.44.3.1077-1080.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Many clinical laboratories are familiar with a sizeable group of “unserotypeable Yersinia enterocolitica” strains. Due to identification problems, this group may hide Y. bercovieri, Y. mollaretii, and Y. rohdei strains. We present a simple scheme to distinguish between pathogenic Y. enterocolitica and potentially nonpathogenic Y. enterocolitica-like strains.

Yersinia enterocolitica, Y. pseudotuberculosis, and Y. pestis have clearly been shown to cause human disease, while characterization of the remaining eight Yersinia species often referred as “Yersinia enterocolitica-like” strains has been more limited. Recently, however, these species thought to be nonpathogenic to humans have been found to possess novel virulence mechanisms, and some of them have been associated with human disease (3, 4, 14, 16, 17). Among these species, identification of Y. bercovieri, Y. mollaretii, and Y. rohdei is a problem for clinical microbiology laboratories because the widely used commercial identification systems (for example, API 20 E, API Rapid 32 IDE, Micronaut E, and the Vitek GNI Card) do not list these species in their databases and usually misidentify them as Y. enterocolitica (10, 11). The identification of Yersinia in clinical microbiology laboratories is generally based on the combination of results from these biochemical identification systems and commercially available antisera against pathogenic serotypes of Y. enterocolitica. In addition, a 16S rRNA gene-based PCR assay for identifying and separating Y. enterocolitica isolates of European and American origin has recently been developed (12). However, this method involves sequencing, which is not easily applicable in most routine clinical microbiology laboratories. In the present study, we provide readers with simple means of recognizing and identifying Y. enterocolitica-like strains, some of which may have pathogenic potential.

In this study, unserotypeable Y. enterocolitica strains (n = 67) isolated and identified by Finnish hospital laboratories were retested at the Enteric Bacteria Laboratory (EBL), National Public Health Institute, with API 20 E (bioMérieux, France) at 30°C and by slide agglutination with antisera against Y. enterocolitica O:3, O:5, O:8, and O:9 (Denka Seiken, Japan). The strains were also biotyped according to Wauters et al. (18), and 55 strains belonged to biotype (BT) 1A (data not shown). Of the remaining 12 strains, 11 were not biotypeable (at least two reactions diverged from the established biotypes), and one strain (IH 111767) was BT 3 but was unserotypeable (Table 1). Thus, their identification as Y. enterocolitica strains was considered doubtful. These strains were further tested for fermentation of sorbose and fucose (at 25°C for 24 and 48 h) and on Congo red-magnesium oxalate agar (CR-MOX test) (13). For comparison, five strains of BTs 1A, 3, and 4 were included (Table 1). The colony morphology of all 17 strains through a stereomicroscope (Olympus [Japan] SZH10 zoom stereomicroscope with an SZH-ILLK illumination base) was examined on cefsulodin-irgasan-novobiocin (CIN) agar (Oxoid) incubated at 30°C for 22 to 24 h and compared to those of Y. enterocolitica (ATCC 9610, NCTC 11176, and RH 4823 [BT 1A control strain of EBL, National Public Health Institute]), Y. mollaretii (ATCC 43969), Y. bercovieri (ATCC 43970), and Y. rohdei (ATCC 43380 and 43872) cultured and incubated in parallel.

Genotyping was performed using hybridization with a YeO:3RS probe as described previously (6). For sequencing, DNA was isolated from bacterial cells by being boiled. Primers (forward, FD1 MOD; and reverse, 533r) were used to amplify the beginning (450 bp) of the 16S rRNA gene sequence (8, 9). Sequences with the 533r primer were determined with an ABIPrism 310 Genetic Analyzer using BigDye fluorescent terminator chemistry (Applied Biosystems, Warrington, United Kingdom).

API 20 E identified 9 of the 12 doubtful strains as Y. enterocolitica with >90% certainty (Table 1). In contrast, sequencing revealed only one Y. enterocolitica strain (identical to ATCC 9610 and NCTC 11176) but five Y. mollaretii strains (0- to 1-nucleotide difference from ATCC 43969), five Y. bercovieri strains (0- to 3-nucleotide difference from ATCC 43970), and one Y. rohdei strain (identical to ATCC 43380). Based on the colony morphology on CIN agar, all of the Y. mollaretii strains and three of the five Y. bercovieri strains (IH 111501, IH 116025, and IH 116028) were tentatively identified as Y. mollaretii or Y. bercovieri, respectively, compared to the reference strains prior to any other testing (Table 1; Fig. 1). The microscopic examination of Y. mollaretii and Y. bercovieri colonies (approximately 1.5 mm in diameter) revealed characteristic erose edges and ground-glass appearance of the translucent zone surrounding the red center of the colonies (best visible in slightly oblique illumination). These features distinguished them from the colonies of Y. enterocolitica BT 1A (approximately 2 mm in diameter, larger center of the colony, and the surrounding zone devoid of ground-glass appearance), serotype O:3 (approximately <1 mm in diameter, smaller, deeper red center of the colony with a sharper border (Fig. 1), and serotype O:9 (data not shown). The rest of the non-Y. enterocolitica strains (IH 41571, IH 116003, and IH 111799) had variable colony morphology (Table 1) that clearly differed from the morphology of Y. enterocolitica. Of the 11 non-Y. enterocolitica strains, it was possible to avoid misidentification as Y. enterocolitica for all 11 strains by colony morphology, but only for 3 strains (IH 41571, IH 116003, and IH 111799) with API 20 E.

In EBL, it has been found useful to start the identification of API 20 E-verified Y. enterocolitica strains received from clinical microbiology laboratories by examining the microscopic colony morphology on CIN agar and by CR-MOX testing. The strains are then forwarded for serotyping (i.e., the appearance of pathogenic serotypes O:3 and O:9), biotyping (the appearance of other strains), and additional biochemical testing (Y. enterocolitica-like appearance and presence of nonbiotypeable strains) if necessary. For example, Y. bercovieri and Y. mollaretii strains, misidentified as Y. enterocolitica, are easily revealed by colony morphology and by negative reactions to esculine, salicine, and lipase and a positive reaction to pyrazinamidase. Y. enterocolitica serotype O:5,27, which is generally less frequently isolated, has a colony morphology sometimes similar to that of Y. bercovieri and Y. mollaretii (Fig. 1), but it can be distinguished by a negative pyrazinamidase reaction with biotyping. In this study, the only exception was the strain IH 111767 with a negative pyrazinamidase reaction, placing it to Y. enterocolitica BT 3, but confirmed as Y. mollaretii after sequencing. Distinguishing between Y. bercovieri and Y. mollaretii can then be made by tests for fucose and sorbose (Table 1) (2, 15). Sequencing is necessary only for a few strains remaining unidentified after these steps, including rare cases of Y. rohdei, pyrazinamidase-negative Y. bercovieri or Y. mollaretii with colony morphology similar to that of Y. enterocolitica O:5,27, and Y. enterocolitica with coinciding atypical morphology and biotype. After introduction of the microscopic morphology in the identification process in EBL, it has been noticed that approximately half of the incoming Y. mollaretii strains have a smooth, mucoid colony type; the other half have a dry, flat colony type (unpublished data).

The cross-reactions of the commercial antisera in serotyping are typical of Y. enterocolitica-like strains and Y. enterocolitica BT 1A (1, 19). In EBL in 2000, the nonserotypeable strains represented about 40% of the incoming Y. enterocolitica strains (7). Therefore, building the identification of Y. enterocolitica solely on the use of these sera, together with a diagnostic kit like API 20 E, is inadequate. For laboratories that have limited capacity for biotyping, the simplest way to avoid misidentifications is to compare the colony morphology of a API 20 E-identified Y. enterocolitica strain with the Y. enterocolitica control strains representing serotypes and/or biotypes O:3/4, O:5,27/2 or O:5,27/3, O:8/1B, O:9/2, O:9/3, and BT 1A.

The probe YeO:3RS contains a region upstream of the Y. enterocolitica O-antigen cluster, a repeated sequence (RS) that is present in multiple copies in the genome. In our previous study (6), the RS was shown to be present only in the genome of the “European” pathogenic serotypes (namely, O:3, O:5,27, O:9, O:1, and O:2) of Y. enterocolitica. The sequence was absent from the genomes of other Y. enterocolitica serotypes and Yersinia species, resulting in a weak or incomplete typing pattern of those strains in that study. The current results are in accordance with the previous observations; none of the Y. enterocolitica-like strains were typeable with the probe compared to the complete typing pattern of the “European” pathogenic bioserotypes in this study. The latter strains were also clearly positive by a CR-MOX test (Table 1).

To summarize, a simple scheme for identification of Y. enterocolitica-like strains is presented. Without accurate identification, already in the primary diagnostics, it is impossible to gain insight into the true clinical significance of Y. enterocolitica-like species. Although the advanced molecular methods are constantly developed, they still may not be available in many routine clinical microbiology laboratories. Therefore, it was interesting to notice how easily the straightforward comparison of the colony morphology of Yersinia isolates can effectively prevent the misidentification of a strain as Y. enterocolitica.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Differentiating between Y. enterocolitica, Y. bercovieri, and Y. mollaretii on CIN agar (incubation at 30°C, 22 to 24 h) through a stereomicroscope (black bar, 1 mm). (a) Y. enterocolitica O:3 (pathogenic serotype, BT 4) appears as characteristically small (approximately <1 mm in diameter), circular colonies with entire edge. The colonies have a small, deep red center (bull's eye) with a sharp border surrounded by a translucent or transparent zone. (b) Y. enterocolitica BT 1A (nonpathogenic biotype). Large (approximately 2 mm in diameter), circular colonies with slightly lighter red center surrounded by a translucent to milk-white zone are shown. The center of the colony is large compared to the surrounding zone and has a blurred border. (c) Y. bercovieri. Erose-edged, slightly irregular circular colonies (approximately 1.5 mm in diameter) are shown, with a medium-red (sometimes pitting) center with an erose border. The surrounding translucent zone has a characteristic ground-glass appearance (best visible by slightly oblique illumination). (d and e) Y. mollaretii. Slightly irregular circular colonies (approximately 1.5 mm in diameter) are shown; a medium-red, diffuse center with no sharp borderline is visible. The surrounding translucent to milk-white zone has a characteristic ground-glass appearance (best visible in slightly oblique illumination). Two types exist: mucoid, with a smoother and more convex appearance (d) and a flat, dry, more irregular- and erose-edged colony (e). It has been noticed in EBL that approximately half of the incoming Y. mollaretii strains have a smooth, mucoid colony type and the other half have a dry, flat colony type (unpublished data). (f) Y. enterocolitica O:5,27 (pathogenic serotype). Circular, usually erose-edged (almost starlike) colonies (approximately 1 to 1.5 mm in diameter) are shown. A small, deep-red center with a slightly blurred border is visible. The surrounding translucent or transparent zone is large, compared to the center (as with Y. enterocolitica O:3), and has a ground-glass appearance.

View this table:
  • View inline
  • View popup
TABLE 1.

Further characterization of Y. enterocolitica strains identified by clinical laboratories

FOOTNOTES

    • Received 22 September 2005.
    • Returned for modification 28 October 2005.
    • Accepted 22 December 2005.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Aleksic, S. 1995. Occurrence of Y. enterocolitica antigens O:3, O:9 and O:8 in different Yersinia species, their corresponding H antigens and origin. Contrib. Microbiol. Immunol.13:89-92.
    OpenUrlPubMed
  2. 2.↵
    Aleksic, S., and J. Bockemühl. 1999. Yersinia and other Enterobacteriaceae, p. 483-491. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
  3. 3.↵
    Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev.10:257-276.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Delor, I., A. Kaeckenbeek, G. Wauters, and G. R. Cornelis. 1990. Nucleotide sequence of yst, the Yersinia enterocolitica gene encoding the heat-stable enterotoxin, and the prevalence of the gene among pathogenic and non-pathogenic yersiniae. Infect. Immun.58:2983-2988.
    OpenUrlAbstract/FREE Full Text
  5. 5.
    Gemski, P., J. R. Lazere, and T. Casey. 1980. Plasmid associated with pathogenicity and calcium dependency of Yersinia enterocolitica. Infect. Immun.27:682-685.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Hallanvuo, S., M. Skurnik, K. Asplund, and A. Siitonen. 2002. Detection of a novel repeated sequence useful for epidemiological typing of pathogenic Yersinia enterocolitica. Int. J. Med. Microbiol.292:215-225.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Hallanvuo, S., and A. Siitonen. 2002. The fecal Yersinia enterocolitica isolates—clinically significant or not? Bull. Natl. Publ. Health Inst. Finl.9:9-10. (In Finnish.)
    OpenUrl
  8. 8.↵
    Jalava, J. 2000. Molecular detection and identification of bacteria based on PCR and rRNA phylogeny—medical applications. Ph.D. thesis. University of Turku, Turku, Finland.
  9. 9.↵
    Kotilainen, P., J. Jalava, O. Meurman, O.-P. Lehtonen, E. Rintala, O.-P. Seppälä, E. Eerola, and S. Nikkari. 1998. Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J. Clin. Microbiol.36:2205-2209.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Linde, H-J., H. Neubauer, H. Meyer, S. Aleksic, and N. Lehn. 1999. Identification of Yersinia species by the Vitek GNI card. J. Clin. Microbiol.37:211-214.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Neubauer, H., T. Sauer, H. Becker, S. Aleksic, and H. Meyer. 1998. Comparison of systems for identification and differentiation of species within the genus Yersinia. J. Clin. Microbiol.36:3366-3368.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Neubauer, H., A. Hensel, S. Aleksic, and H. Meyer. 2000. Identification of Yersinia enterocolitica within the genus Yersinia. Syst. Appl. Microbiol.23:58-62.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Riley, G., and S. Toma. 1989. Detection of pathogenic Yersinia enterocolitica by using Congo red-magnesium oxalate agar medium. J. Clin. Microbiol.27:213-214.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Robins-Browne, R. M., S. Ciancosi, A.-M. Bordun, and G. Wauters. 1991. Pathogenicity of Yersinia kristensenii for mice. Infect. Immun.59:162-167.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Stock, I., B. Henrichfreise, and B. Wiedemann. 2002. Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and ‘Y. ruckeri.’ J. Med. Microbiol.51:56-69.
    OpenUrlPubMedWeb of Science
  16. 16.↵
    Sulakvelidze, A. 2000. Yersiniae other than Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis: the ignored species. Microbes Infect.2:497-513.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Sulakvelidze, A., A. Kreger, A. Joseph, et al. 1999. Production of enterotoxin by Yersinia bercovieri, a recently identified Yersinia enterocolitica-like species. Infect. Immun.67:968-971.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Wauters, G., K. Kandolo, and M. Janssens. 1987. Revised biogrouping scheme of Yersinia enterocolitica. Contrib. Microbiol. Immunol.9:14-21.
    OpenUrlPubMed
  19. 19.↵
    Wauters, G., M. Janssens, A. G. Steigerwalt, and D. J. Brenner. 1988. Yersinia mollaretii sp. nov., Yersinia bercovieri sp. nov., formerly called Yersinia enterocolitica biogroups 3A and 3B. Int. J. Syst. Bacteriol.38:424-429.
    OpenUrlCrossRef
PreviousNext
Back to top
Download PDF
Citation Tools
Simplified Phenotypic Scheme Evaluated by 16S rRNA Sequencing for Differentiation between Yersinia enterocolitica and Y. enterocolitica-Like species
Saija Hallanvuo, Joanna Peltola, Tarja Heiskanen, Anja Siitonen
Journal of Clinical Microbiology Mar 2006, 44 (3) 1077-1080; DOI: 10.1128/JCM.44.3.1077-1080.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Simplified Phenotypic Scheme Evaluated by 16S rRNA Sequencing for Differentiation between Yersinia enterocolitica and Y. enterocolitica-Like species
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Simplified Phenotypic Scheme Evaluated by 16S rRNA Sequencing for Differentiation between Yersinia enterocolitica and Y. enterocolitica-Like species
Saija Hallanvuo, Joanna Peltola, Tarja Heiskanen, Anja Siitonen
Journal of Clinical Microbiology Mar 2006, 44 (3) 1077-1080; DOI: 10.1128/JCM.44.3.1077-1080.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

RNA, Bacterial
RNA, Ribosomal, 16S
Yersinia
Yersinia enterocolitica

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X